Pruritus assessment in clinical Trials: consensus recommendations from the International Forum for the Study of Itch (IFSI) Special Interest Group Scoring Itch in Clinical Trials
Standard
Pruritus assessment in clinical Trials: consensus recommendations from the International Forum for the Study of Itch (IFSI) Special Interest Group Scoring Itch in Clinical Trials. / Ständer, Sonja; Augustin, Matthias; Reich, Adam; Blome, Christine; Ebata, Toshiya; Phan, Ngoc Quan; Szepietowski, Jacek C.
In: ACTA DERM-VENEREOL, Vol. 93, No. 5, 04.09.2013, p. 509-14.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Pruritus assessment in clinical Trials: consensus recommendations from the International Forum for the Study of Itch (IFSI) Special Interest Group Scoring Itch in Clinical Trials
AU - Ständer, Sonja
AU - Augustin, Matthias
AU - Reich, Adam
AU - Blome, Christine
AU - Ebata, Toshiya
AU - Phan, Ngoc Quan
AU - Szepietowski, Jacek C
PY - 2013/9/4
Y1 - 2013/9/4
N2 - Chronic pruritus is a common symptom and there is an urgent need to test new anti-pruritic substances in high-quality clinical trials. However, no widely accepted standardized and validated method for objectively measuring pruritus is yet available. A special interest group of the International Forum for the Study of Itch has been established to assess scoring methods and questionnaires for use in clinical trials. This paper presents our current recommendations. The set of measures we recommend includes pruritus intensity scales, instruments for assessment of scratch lesions, chronic pruritus course, quality of life and patient benefits.
AB - Chronic pruritus is a common symptom and there is an urgent need to test new anti-pruritic substances in high-quality clinical trials. However, no widely accepted standardized and validated method for objectively measuring pruritus is yet available. A special interest group of the International Forum for the Study of Itch has been established to assess scoring methods and questionnaires for use in clinical trials. This paper presents our current recommendations. The set of measures we recommend includes pruritus intensity scales, instruments for assessment of scratch lesions, chronic pruritus course, quality of life and patient benefits.
KW - Antipruritics
KW - Chronic Disease
KW - Clinical Trials as Topic
KW - Humans
KW - Predictive Value of Tests
KW - Pruritus
KW - Quality of Life
KW - Questionnaires
KW - Research Design
KW - Severity of Illness Index
KW - Treatment Outcome
U2 - 10.2340/00015555-1620
DO - 10.2340/00015555-1620
M3 - SCORING: Journal article
C2 - 23624777
VL - 93
SP - 509
EP - 514
JO - ACTA DERM-VENEREOL
JF - ACTA DERM-VENEREOL
SN - 0001-5555
IS - 5
ER -